The treatment of coronary heart disease: An update. Part 5: Selected comments and questionsMIKHAILIDIS, Dimitri P.Current medical research and opinion. 2001, Vol 17, Num 1, pp 41-42, issn 0300-7995Article

Are high density lipoprotein (HDL) and triglyceride levels relevant in stroke prevention?RIZOS, Evangelos; MIKHAILIDIS, Dimitri P.Cardiovascular research. 2001, Vol 52, Num 2, pp 199-207, issn 0008-6363Article

Lipid Lowering Drugs and Gallstones: A Therapeutic Option? : New Developments in the Prevention and Treatment of Vascular Disease: 2LIOUDAKI, Eirini; GANOTAKIS, Emmanuel S; MIKHAILIDIS, Dimitri P et al.Current pharmaceutical design (Print). 2011, Vol 17, Num 33, pp 3622-3631, issn 1381-6128, 10 p.Article

Apolipoprotein E polymorphism and atherosclerosisKOLOVOU, Genovefa; DASKALOVA, Deliana; MIKHAILIDIS, Dimitri P et al.Angiology. 2003, Vol 54, Num 1, pp 59-71, issn 0003-3197, 13 p.Article

Beyond LDL-C - the importance of raising HDL-CWIERZBICKI, Anthony S; MIKHAILIDIS, Dimitri P.Current medical research and opinion. 2002, Vol 18, Num 1, pp 36-44, issn 0300-7995Article

Summarizing the FIELD study: lessons from a 'negative' trialTSIMIHODIMOS, Vasilis; MIKHAILIDIS, Dimitri P; ELISAF, Moses et al.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 18, pp 2601-2610, issn 1465-6566, 10 p.Article

Influence of smoking on predictors of vascular diseaseTSIARA, Stavroula; ELISAF, Moses; MIKHAILIDIS, Dimitri P et al.Angiology. 2003, Vol 54, Num 5, pp 507-530, issn 0003-3197, 24 p.Article

Naltrexone sustained-release (SR) + bupropion SR combination therapy for the treatment of obesity: 'A new kid on the block'?KATSIKI, Niki; HATZITOLIOS, Apostolos I; MIKHAILIDIS, Dimitri P et al.Annals of medicine (Helsinki). 2011, Vol 43, Num 3-4, pp 249-258, issn 0785-3890, 10 p.Article

Statins : An essential component in the management of carotid artery diseasePARASKEVAS, Kosmas I; HAMILTON, George; MIKHAILIDIS, Dimitri P et al.Journal of vascular surgery. 2007, Vol 46, Num 2, pp 373-386, issn 0741-5214, 14 p.Article

Smoking diminishes the beneficial effect of statins : Observations from the landmark trialsMILIONIS, Haralampos J; RIZOS, Evangelos; MIKHAILIDIS, Dimitri P et al.Angiology. 2001, Vol 52, Num 9, pp 575-587, issn 0003-3197Article

Drug-induced fibrotic valvular heart diseaseBHATTACHARYYA, Sanjeev; SCHAPIRA, Anthony H; MIKHAILIDIS, Dimitri P et al.Lancet (British edition). 2009, Vol 374, Num 9689, pp 577-585, issn 0140-6736, 9 p.Article

Effect of ciprofibrate on C-reactive protein and fibrinogen levelsRIZOS, Evagelos; KOSTOULA, Angeliki; ELISAF, Moses et al.Angiology. 2002, Vol 53, Num 3, pp 273-277, issn 0003-3197Article

Comparison of the five 2011 guidelines for the treatment of carotid stenosisPARASKEVAS, Kosmas I; MIKHAILIDIS, Dimitri P; VEITH, Frank J et al.Journal of vascular surgery. 2012, Vol 55, Num 5, pp 1504-1508, issn 0741-5214, 5 p.Article

Optimal statin type and dosage for vascular patientsPARASKEVAS, Kosmas I; MIKHAILIDIS, Dimitri P; VEITH, Frank J et al.Journal of vascular surgery. 2011, Vol 53, Num 3, pp 837-844, issn 0741-5214, 8 p.Article

Mechanisms to explain the poor results of carotid artery stenting (CAS) in symptomatic patients to date and options to improve CAS outcomesPARASKEVAS, Kosmas I; MIKHAILIDIS, Dimitri P; VEITH, Frank J et al.Journal of vascular surgery. 2010, Vol 52, Num 5, pp 1367-1375, issn 0741-5214, 9 p.Article

The effects of lipid-regulating therapy on haemostatic parametersMILIONIS, Haralampos J; ELISAF, Moses S; MIKHAILIDIS, Dimitri P et al.Current pharmaceutical design. 2003, Vol 9, Num 29, pp 2425-2443, issn 1381-6128, 19 p.Article

Colesevelam: A New and Improved Bile Acid Sequestrant? : Current and Future Options for Lipid-lowering Therapy Beyond StatinsTZIOMALOS, Konstantinos; KARAGIANNIS, Asterios; MIKHAILIDIS, Dimitri P et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 17, pp 3115-3123, issn 1381-6128, 9 p.Article

Apolipoprotein E Knockout Models : Experimental Models for the Study of Drugs Used to Prevent and Treat Vascular DiseasesKOLOVOU, Genovefa; ANAGNOSTOPOULOU, Katherine; MIKHAILIDIS, Dimitri P et al.Current pharmaceutical design. 2008, Vol 14, Num 4, pp 338-351, issn 1381-6128, 14 p.Article

The choice of antihypertensive drugs in patients with erectile dysfunctionKHAN, Masood A; MORGAN, Robert J; MIKHAILIDIS, Dimitri P et al.Current medical research and opinion. 2002, Vol 18, Num 2, pp 103-107, issn 0300-7995Article

The Role of Fibrate Treatment in Dyslipidemia: An Overview : Current and Future Options for Lipid-lowering Therapy Beyond StatinsKATSIKI, Niki; NIKOLIC, Dragana; MONTALTO, Giuseppe et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 17, pp 3124-3131, issn 1381-6128, 8 p.Article

The Pathogenetic Role of Cortisol in the Metabolic Syndrome: A HypothesisANAGNOSTIS, Panagiotis; ATHYROS, Vasilios G; TZIOMALOS, Konstantinos et al.The Journal of clinical endocrinology and metabolism. 2009, Vol 94, Num 8, pp 2692-2701, issn 0021-972X, 10 p.Article

Vascular risk factors in South AsiansTZIOMALOS, Konstantinos; WEERASINGHE, Charitha N; MIKHAILIDIS, Dimitri P et al.International journal of cardiology. 2008, Vol 128, Num 1, pp 5-16, issn 0167-5273, 12 p.Article

The role of serotonin in tumour growthSIDDIQUI, Emad J; THOMPSON, Cecil S; MIKHAILIDIS, Dimitri P et al.Oncology reports. 2005, Vol 14, Num 6, pp 1593-1597, issn 1021-335X, 5 p.Article

Combined Dyslipidemia: Should the Focus be LDL Cholesterol or Atherogenic Dyslipidemia? : Achieving Curent Goals in Prevention and Treatment of Vascular Disease: An UpdateRIZZO, Manfredi; BARYLSKI, Marcin; RIZVI, Ali A et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 21, pp 3858-3868, issn 1381-6128, 11 p.Article

Mean Platelet Volume: A Link Between Thrombosis and Inflammation?YURI GASPARYAN, Armen; AYVAZYAN, Lilit; MIKHAILIDIS, Dimitri P et al.Current pharmaceutical design (Print). 2011, Vol 17, Num 1, pp 47-58, issn 1381-6128, 12 p.Article